skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Gallium Ga 68-labeled-NODAGA-MJ9 (Code C115960)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Gallium Ga 68-labeled-NODAGA-MJ9

Definition: A radiopharmaceutical agent comprised of a peptide targeting the gastrin releasing peptide receptor (GRPR) chelated with 1,4,7-triazacyclononane,1-glutaric acid-4,7 acetic acid (NODAGA) and radiolabeled with gallium Ga 68, with potential tumor imaging activity upon positron emission tomography (PET). After administration of gallium Ga 68-labeled-NODAGA-MJ9, the MJ9 moiety binds to GRPR located on tumor cells. Upon PET imaging, GRPR-expressing tumor cells can be visualized and expression levels can be quantified. GRPR is overexpressed on certain tumor cells and plays a key role in tumor proliferation and survival.

Label: Gallium Ga 68-labeled-NODAGA-MJ9

NCI Thesaurus Code: C115960 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL473297  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Gallium Ga 68-labeled-NODAGA-MJ9

External Source Codes: 
PDQ Closed Trial Search ID 760313
PDQ Open Trial Search ID 760313 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C115960
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom